Ex Vivo News and Research

RSS
New trials show promise for immune checkpoint blockers in early-stage lung cancer

New trials show promise for immune checkpoint blockers in early-stage lung cancer

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Normothermic regional perfusion could increase the number of patients receiving lung transplants

Normothermic regional perfusion could increase the number of patients receiving lung transplants

New insights into the exacerbation of psoriasis through specific genetic defects

New insights into the exacerbation of psoriasis through specific genetic defects

Breakthrough in CRISPR delivery promises safer gene editing

Breakthrough in CRISPR delivery promises safer gene editing

New catheter-based device images heart disease plaques with unprecedented detail

New catheter-based device images heart disease plaques with unprecedented detail

Discovery of bicarbonate-sensing receptor offers therapeutic insights into ischemic stroke treatment

Discovery of bicarbonate-sensing receptor offers therapeutic insights into ischemic stroke treatment

Natural killer cells lead the charge in cancer treatment innovation

Natural killer cells lead the charge in cancer treatment innovation

How does melanin distribution impact UV damage?

How does melanin distribution impact UV damage?

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

Breakthrough gene-editing therapy transforms lives of patients with a hereditary disorder

CRISPR revolutionized: New method edits genes directly in the body

CRISPR revolutionized: New method edits genes directly in the body

How does the nasal cavity's immune system combat SARS-CoV-2?

How does the nasal cavity's immune system combat SARS-CoV-2?

COST Action bridges the gap in cancer immunotherapy research

COST Action bridges the gap in cancer immunotherapy research

Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

Nanobots for bladder cancer treatment, promising high efficacy and targeted delivery

Scripps scientists debunk long-held theory about alcohol and the brain

Scripps scientists debunk long-held theory about alcohol and the brain

Growing tiny tumors in the lab for personalized lung cancer treatment

Growing tiny tumors in the lab for personalized lung cancer treatment

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

EZH2 inhibitors show promise in regenerating insulin-producing cells for type 1 diabetes treatment

Study links omicron's cellular senescence to inflammation and long-COVID risk

Study links omicron's cellular senescence to inflammation and long-COVID risk

New insights into the cellular programs that promote resolution of inflammation during aging

New insights into the cellular programs that promote resolution of inflammation during aging

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.